
Injective launches an on-chain Pre-IPO market, offering global investors the ability to trade synthetic assets tied to private company valuations, such as OpenAI, with up to 5x leverage.
Injective has launched an on-chain Pre-IPO market that allows global investors to trade synthetic assets representing the valuations of private companies, including OpenAI. The platform offers up to 5x leverage, enabling users to amplify exposure to these assets and providing a decentralized alternative for early access to private market valuations.